RBC initiated coverage of Grail with a Sector Perform rating and $84 target, citing Galleri’s potent

On Thursday, Illumina (NASDAQ:ILMN) discussed second-quarter financial results during its earnings c

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.87% on an annualized

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Baird Financial Group Inc. lowered its stake in Illumina, Inc. (NASDAQ: ILMN) by 14.6% in the undefi

Analysts upgraded SFNC, OBIO, and more.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and i

UBS analyst Doug Schenkel upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the pric

The S&P 500 is set for another shakeup, with Bloom Energy (BE), Everpure (P), and Illumina (ILMN) al

Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicin

Illumina (ILMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the co

NEW YORK, Sept. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the

AI energy play Bloom Energy will be added to the S&P 500 index on Sept. 21. Illumina and Everpure al

https://www.spglobal.com/spdji/en//documents/indexnews/announcements/20260904-1484999/1484999_shuffl

Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified ex

AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Market Updates News Commentary - Earnings season i

Argus Research analyst Jasper Hellweg maintains Illumina (NASDAQ:ILMN) with a Buy and raises the

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized

ILMN's sequencing growth, oncology momentum and multiomics expansion support its outlook, though cos

On August 19, 2026, Merck (NYSE:MRK | MRK Price Prediction) and Moderna (NASDAQ:MRNA) announced posi

Biondo Investment Advisors LLC bought a new stake in shares of Illumina, Inc. (NASDAQ: ILMN) in the

Allworth Financial LP acquired a new position in Illumina, Inc. (NASDAQ: ILMN) in the second quarter

Illumina delivered strong Q2 2026 results, beating on EPS and revenue, and raised full-year guidance

Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in fou

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Empowered Funds LLC raised its stake in Illumina, Inc. (NASDAQ: ILMN) by 104.2% during the first qua

Illumina (ILMN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized

Canaccord Genuity analyst Kyle Mikson maintains Illumina (NASDAQ:ILMN) with a Hold and raises the

Citigroup analyst Joanne Wuensch maintains Illumina (NASDAQ:ILMN) with a Sell and raises the pric

Piper Sandler analyst David Westenberg reiterates Illumina (NASDAQ:ILMN) with a Overweight and ra

RBC Capital analyst Dan Leonard maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the

JP Morgan analyst Casey Woodring maintains Illumina (NASDAQ:ILMN) with a Overweight and raises th

TD Cowen analyst Dan Brennan maintains Illumina (NASDAQ:ILMN) with a Hold and raises the price ta

Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price t

Stifel analyst Daniel Arias maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price targ

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the

Illumina (NASDAQ:ILMN) raises FY2026 Adj EPS guidance from $5.15-$5.30 to $5.30-$5.40 vs $5.23 analy

Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics an

Leerink Partners analyst Puneet Souda maintains Illumina (NASDAQ:ILMN) with a Outperform and rais

Canaccord Genuity analyst Kyle Mikson maintains Illumina (NASDAQ:ILMN) with a Hold and raises the

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Evercore ISI Group analyst Vijay Kumar maintains Illumina (NASDAQ:ILMN) with a Outperform and rai